ABEO

Abeona Therapeutics Inc. Common Stock
Data: 2026-01-30
$5.09
Price
0.49%
Change
$7.5401
52W High
$3.9328
52W Low

Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.

Quick Stats
Jan 30, 2026

56.1

AI Score

HOLD

0.59

Volume Ratio

Mar 19, 2026

Next Earnings

15

+ve Days (30d)

13

-ve Days (30d)

ABEO Stock Summary

Last updated Jan 30, 2026

ABEO is currently trading at $5.09, positioned below its 200-day moving average of $5.7, suggesting bearish momentum. The stock has a 52-week range of $3.9328 to $7.5401.

Technical Analysis: The 50-day moving average stands at $5.07, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 47.748, suggesting the stock is neutral with balanced momentum.

Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.045, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates ABEO at 56.1/100 with a HOLD recommendation.

ABEO (Abeona Therapeutics Inc. Common Stock) Indicators

Last updated Jan 30, 2026

Indicator Value
RSI(14) 47.748
CMF (20) 0.045
ROC (10) -6.606
ADX (14) 16.246
Indicator Value
MACD (12,26,9) -0.014
AROONOSC (14) -50.0
WILLAMS %R (14) -66.111
MFI (14) 51.847
ABEO Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators

Select indicators above to analyze technical patterns

Indicators will appear below the price chart with perfectly aligned dates

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

ABEO Price vs Max Options Open Interest
ABEO Max Change In Options Open Interest

ABEO Options - Sort by Max open Interest (near term)

2nd February 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

ABEO Daily Out of Money Options - Sort by Max open Interest (near term)

2nd February 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

ABEO Daily In the Money Options - Sort by Max open Interest (near term)

2nd February 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

ABEO Most Active Options by Volume(near term)

2nd February 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI
Ask PC Delta Vega Volatility % change Track

Abeona Therapeutics Inc. Common Stock is not trading above both 50 Day and 200 Day SMA which is considered Bearish.

ABEO Moving Averages Analysis

Abeona Therapeutics Inc. Common Stock has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Jan 30, 2026

ABEO (Abeona Therapeutics Inc. Common Stock) Simple Moving Averages

Moving Averages are last updated Jan 30, 2026

Days MA
10 5.17
20 5.19
30 5.2
50 5.07
100 5.18
200 5.7

ABEO Fundamental Analysis

P/E (Forward) 500
P/E (Trailing) 4.124
Market Cap ($) 270.4 million
Earnings/Share ($) 1.21
Net Proft Margin (%) 205.875
Dividend/Share ($) --
EPS Estimate Current Year ($) -0.135
EPS Estimate Next Year ($) -0.07
WallStreet Target Price ($) 20.6429
Most Recent Quarter